MECHANISMS FOR KETOAMIDE ESCAPE IN VAL55 VARIANTS OF THE HCV NS3/4A PROTEASE DOMAIN

被引：0
|
作者：
Welsch, C. [1 ,2 ,3 ]
Schweizer, S. [4 ,5 ]
Shimakami, T. [3 ]
Antes, I. [4 ,5 ]
Zeuzem, S. [1 ]
Lemon, S. [3 ]
机构：
[1] Goethe Univ Frankfurt, Med Klin 1, Frankfurt, Germany
[2] Max Planck Inst Informat, Saarbrucken, Germany
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Tech Univ Munich, Munich, Germany
[5] Kanazawa Univ, Kanazawa, Ishikawa, Japan
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)61226-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1214
引用
收藏
页码：S482 / S482
页数：1
相关论文
共 50 条
  • [31] Bismacrocyclic Inhibitors of Hepatitis C NS3/4a Protease
    McCauley, John A.
    Rudd, Michael T.
    Nguyen, Kevin T.
    McIntyre, Charles J.
    Romano, Joseph J.
    Bush, Kimberly J.
    Varga, Sandor L.
    Ross, Charles W., III
    Carroll, Steven S.
    DiMuzio, Jillian
    Stahlhut, Mark W.
    Olsen, David B.
    Lyle, Terry A.
    Vacca, Joseph P.
    Liverton, Nigel J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (47) : 9104 - 9107
  • [32] Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor
    Matthews, Samuel James
    Lancaster, Jason W.
    CLINICAL THERAPEUTICS, 2012, 34 (09) : 1857 - 1882
  • [33] Development of recombinant replicon reporter assays for characterization of HCV NS5A and NS3/4A protease inhibitors
    Huang, W.
    Newton, A.
    Toma, J.
    Cook, J.
    Choe, S.
    Frantzell, A.
    Anton, E.
    Rivera, A.
    Fransen, K.
    Han, D.
    Whitcomb, J.
    Reeves, J.
    Petropoulos, C. J.
    ANTIVIRAL THERAPY, 2011, 16 : A29 - A29
  • [34] Furaprevir HCV NS3/4A protease inhibitor Treatment of chronic hepatitis C virus infection
    Ghosh, Prithwish
    Nehra, Vandana
    Temesgen, Zelalem
    DRUGS OF THE FUTURE, 2022, 47 (08) : 557 - 565
  • [35] Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant Variants
    Rusere, Linah N.
    Matthew, Ashley N.
    Lockbaum, Gordon J.
    Jahangir, Muhammad
    Newton, Alicia
    Petropoulos, Christos J.
    Huang, Wei
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    Ali, Akbar
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (07): : 691 - 696
  • [36] PRECLINICAL CHARACTERIZATION OF NON-COVALENT HCV NS3/4A PROTEASE INHIBITOR BI 201335
    White, P. W.
    Llinas-Brunet, M.
    Amad, M.
    Bolger, G.
    Cordingley, M. G.
    Duan, J.
    Garneau, M.
    Lagace, L.
    Thibeault, D.
    Kukolj, G.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S302 - S302
  • [37] IDENTIFICATION OF NOVEL NON-MACROCYCLIC INHIBITORS OF HCV NS3/4A SERINE PROTEASE ACTIVITY
    Buckman, Brad O.
    Pan, Lin
    Huang, Lea
    Kossen, Karl
    Rajagopalan, Ravi
    Misialek, Shawn
    Stevens, Sarah K.
    Tan, Hua
    Ruhrmund, Donald
    Serebryany, Vladimir
    Matulik-Adamic, Jasenka
    Stoycheva, Antitsa
    Ammons, Steve
    Fuhrer, Douglas K.
    Blatt, Lawrence M.
    Beigelman, Leo
    Seiwert, Scott
    HEPATOLOGY, 2008, 48 (04) : 1164A - 1165A
  • [38] CHARACTERIZATION OF RESISTANT MUTANTS SELECTED IN VITRO BY THE HCV NS3/4A PROTEASE INHIBITOR BI 201335
    Kukolj, G.
    Bousquet, C.
    Dansereau, N.
    Do, F.
    Lagace, L.
    Llinas-Brunet, M.
    Marquis, M.
    Massariol, M. -J.
    Maurice, R.
    Spickler, C.
    Thibeault, D.
    Zhao, S.
    White, P. W.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S295 - S295
  • [39] Design and synthesis of new HCV NS3/4A protease inhibitors to effective against drug resistance
    Oksuz, Zehra
    Aktekin, Mine Buga
    Alagoz, Mehmet Abdullah
    Kuzucu, Mehmet
    Serin, Mehmet Sami
    Algul, Oztekin
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1336
  • [40] Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir
    Timm, Jennifer
    Kosovrasti, Klajdi
    Henes, Mina
    Leidner, Florian
    Hou, Shurong
    Ali, Akbar
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    ACS CHEMICAL BIOLOGY, 2020, 15 (02) : 342 - 352
12345